Fundz

Excepgen Emerges From Stealth With New Funding For Its Nucleic Acid Therapeutics Platform

PRIVATEAug 24, 2023

Round Type

Funding Round

San FranciscoBiotechnologyTherapeutics

Investors

Apollo ProjectsGravity FundRA Capital Management

Description

ExcepGen, a genetic medicine startup, emerged from stealth after the successful completion of its newest funding round. The most recent $4 million round, which brings the company's total seed funding to $14 million, was led by RA Capital Management and backed by Gravity Fund, Apollo Projects (Sam Altman), and other premier investors.

Quick answer

ExcepGen raised an undisclosed amount in a Funding Round round, dated August 24, 2023. Investors: Apollo Projects, Gravity Fund and RA Capital Management. ExcepGen is based in San Francisco, California, United States.

How much did ExcepGen raise?
ExcepGen raised an undisclosed amount in a Funding Round round on August 24, 2023.
Who invested in ExcepGen?
Apollo Projects, Gravity Fund and RA Capital Management are named as investors in this round.
What does ExcepGen do?
ExcepGen is an early-stage biotechnology company at the forefront of the nucleic acid therapeutics revolution.
Where is ExcepGen based and how big is it?
ExcepGen is based in San Francisco, California, United States.
Who are the decision-makers at ExcepGen?
Fundz holds 1 contact at ExcepGen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as ExcepGen that raised within 45 days of this round, from Fundz verified event records.

  • Amicus Therapeutics raised an undisclosed amount (Funding Round) on October 2, 2023.
  • Medicus Pharma raised $11M (Seed) on September 29, 2023.
  • Acasti raised $7.5M (Post-IPO Equity) on September 26, 2023.
  • Acasti raised $7.5M on September 25, 2023.
  • Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
  • Entero Therapeutics raised $1.5M (Seed) on September 14, 2023.

Who to call at ExcepGen, and when

A new round usually means ExcepGen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ExcepGen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ExcepGen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ExcepGen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ExcepGen

Location

San Francisco, California, United States

About

ExcepGen is an early-stage biotechnology company at the forefront of the nucleic acid therapeutics revolution. Leveraging its proprietary platform, the company aims to expand the boundaries for RNA and DNA-based therapies and open the door to entirely new classes of genetic medicines. ExcepGen was co-founded by Barbara Mertins and Thomas Folliard and is based in San Francisco.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ExcepGen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ExcepGen's next move

See what Strategic adds

ExcepGen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.